MacroGenics Announces Achievement of $15 Million Milestone Related to Gilead’s Nomination of a Bispecific Research Program
Go back to MacroGenics Announces Achievement of $15 Million Milestone Related to Gilead’s Nomination of a Bispecific Research Program| Gilead Sciences (NASDAQ: GILD) | Delayed: 152.38 +1.49 (0.99%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $150.89 | 52 Week High | $108.63 | |||
| Open | $150.56 | 52 Week Low | $71.39 | |||
| Day High | $152.80 | P/E | 84.19 | |||
| Day Low | $150.10 | EPS | $1.81 | |||
| Volume | 1,768,868 | |||||
| MACROGENICS (NASDAQ: MGNX) | Delayed: 4.10 -0.03 (0.73%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.13 | 52 Week High | $36.11 | |||
| Open | $4.12 | 52 Week Low | $14.84 | |||
| Day High | $4.12 | P/E | 10.51 | |||
| Day Low | $4.10 | EPS | $0.39 | |||
| Volume | 45,349 | |||||

